[HTML][HTML] Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast …
HJ Burstein, G Curigliano, B Thürlimann, WP Weber… - Annals of oncology, 2021 - Elsevier
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
[HTML][HTML] Breast cancer treatment
KP Trayes, SEH Cokenakes - American family physician, 2021 - aafp.org
Breast cancer is the leading cause of death from cancer in women worldwide, and the
second most common cause of death from cancer in women in the United States. Risk …
second most common cause of death from cancer in women in the United States. Risk …
Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology
WJ Gradishar, MS Moran, J Abraham, R Aft… - Journal of the National …, 2022 - jnccn.org
The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
[HTML][HTML] Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer
TJ Whelan, S Smith, S Parpia, AW Fyles… - … England Journal of …, 2023 - Mass Medical Soc
Background Adjuvant radiotherapy is prescribed after breast-conserving surgery to reduce
the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated …
the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated …
[HTML][HTML] Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non …
AM Brunt, JS Haviland, DA Wheatley, MA Sydenham… - The Lancet, 2020 - thelancet.com
Background We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation
therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as …
therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as …
Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: Long-term results of the randomized phase III APBI-IMRT …
I Meattini, L Marrazzo, C Saieva, I Desideri… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To report the long-term results of external-beam accelerated partial-breast
irradiation (APBI) intensity-modulated radiation therapy (IMRT) Florence phase III trial …
irradiation (APBI) intensity-modulated radiation therapy (IMRT) Florence phase III trial …
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial
R Orecchia, U Veronesi, P Maisonneuve… - The Lancet …, 2021 - thelancet.com
Background In the randomised, phase 3 equivalence trial on electron intraoperative
radiotherapy (ELIOT), accelerated partial breast irradiation (APBI) with the use of …
radiotherapy (ELIOT), accelerated partial breast irradiation (APBI) with the use of …
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a
single dose during lumpectomy, can effectively replace postoperative whole breast external …
single dose during lumpectomy, can effectively replace postoperative whole breast external …
[HTML][HTML] Recent advances in radiotherapy of breast cancer
J Haussmann, S Corradini, C Nestle-Kraemling… - Radiation …, 2020 - Springer
Radiation therapy is an integral part of the multidisciplinary management of breast cancer.
Regional lymph node irradiation in younger trials seems to provide superior target coverage …
Regional lymph node irradiation in younger trials seems to provide superior target coverage …
Updated standardized definitions for efficacy end points (STEEP) in adjuvant breast cancer clinical trials: STEEP version 2.0
SM Tolaney, E Garrett-Mayer, J White… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007, provide standardized definitions of adjuvant breast cancer clinical trial …
established in 2007, provide standardized definitions of adjuvant breast cancer clinical trial …